Laparoscopic sleeve gastrectomy in obese patients with ventricular assist devices: a data note

Autor: Juan Francisco Loro-Ferrer, Sapna Desai, Hamang Patel, Stacy A. Mandras, Adrian daSilva-deAbreu, Carl J. Lavie, Selim R. Krim, Hector O. Ventura, Kiran Garikapati, Clement Eiswirth, Bader Aldeen Alhafez
Rok vydání: 2020
Předmět:
Weight loss
medicine.medical_specialty
medicine.medical_treatment
lcsh:Medicine
Heart failure
030209 endocrinology & metabolism
Heart transplantation
030204 cardiovascular system & hematology
Data Note
General Biochemistry
Genetics and Molecular Biology
Body Mass Index
Ventricular assist devices
03 medical and health sciences
0302 clinical medicine
Gastrectomy
Humans
Medicine
Obesity
cardiovascular diseases
lcsh:Science (General)
lcsh:QH301-705.5
Contraindication
Retrospective Studies
Bariatric surgery
business.industry
Medical record
lcsh:R
General Medicine
Perioperative
medicine.disease
Obesity
Morbid
Surgery
Laparoscopic sleeve gastrectomy
Metabolism
Treatment Outcome
lcsh:Biology (General)
Echocardiography
Laparoscopy
Heart-assist devices
medicine.symptom
business
Complication
Body mass index
lcsh:Q1-390
Zdroj: BMC Research Notes, Vol 13, Iss 1, Pp 1-3 (2020)
BMC Research Notes
ISSN: 1756-0500
DOI: 10.1186/s13104-020-05272-2
Popis: Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT). The objective was to analyze the outcomes of obese patients with ESHF and VADs who underwent laparoscopic sleeve gastrectomy (LSG) at Ochsner Medical Center in New Orleans, which is the only program performing VADs and HT in the State of Louisiana, and also one of the largest VAD centers in the USA. Data description This dataset contains detailed baseline, perioperative, and long-term data of patients with VADs undergoing LSG. These variables were collected retrospectively from electronic medical records. Patients who achieved ≥ 50% excess BMI loss, BMI ≤ 35 kg/m2, listing for HT, HT, or myocardial recovery were identified and the timing to each of these milestones was documented. These data can be used alone or in combination with other datasets to achieve a larger sample size with more power for further analysis of these variables, which include the most important, standard, and objective bariatric and ESHF outcomes of patients with VADs undergoing LSG. Elaboration of composite outcomes is feasible.
Databáze: OpenAIRE
Externí odkaz: